/
DGX
$234.40-$1.64 (-0.69%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$26.2B
110M shares
52-week range
$171.18 – $240.13
92% from low
Sector
SERVICES-MEDICAL LABORATORIES
Exchange
NYSE
CS
Change+$83.05
Quest Diagnostics Inc.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
www.questdiagnostics.com- Employees
- 57,000
- IPO / List date
- Dec 17, 1996
- HQ
- SECAUCUS, NJ
Held by traders on TradeandTell
No one on the platform currently holds DGX.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2024-09-30 | 38,100 | $5.9M |
| Bridgewater Associatesas of 2026-03-31 | 3,471 | $680.2K |
Insider activity (SEC Form 4)
Dividend history
TTM yield · 1.44% ($3.38/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-10-06 | $0.8600 | 2026-10-21 |
| 2026-07-08 | $0.8600 | 2026-07-22 |
| 2026-04-06 | $0.8600 | 2026-04-20 |
| 2026-01-13 | $0.8000 | 2026-01-28 |
| 2025-10-03 | $0.8000 | 2025-10-20 |
| 2025-07-07 | $0.8000 | 2025-07-21 |
| 2025-04-07 | $0.8000 | 2025-04-21 |
| 2025-01-14 | $0.7500 | 2025-01-29 |
| 2024-10-04 | $0.7500 | 2024-10-21 |
| 2024-07-08 | $0.7500 | 2024-07-22 |
Recent trades on TradeandTell
No one on the platform has traded DGX yet.
